Clinical Trial Update: Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib in relapsed/refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Goethe University | Conditions: AML | Phase 2 | Status: COMPLETED